Literature DB >> 33340329

Corrigendum to: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.

Quinn T Ostrom, Nirav Patil, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan.   

Abstract

Entities:  

Year:  2022        PMID： 33340329      PMCID： PMC9248396          DOI： 10.1093/neuonc/noaa269

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  10 in total

1.  Minimizing OCT quantification error via a surface-tracking imaging probe.

Authors:  Hyeon-Cheol Park; Ang Li; Honghua Guan; Chetan Bettegowda; Kaisorn Chaichana; Alfredo Quiñones-Hinojosa; Xingde Li
Journal:  Biomed Opt Express       Date:  2021-06-10       Impact factor: 3.562

2.  Retrospective study of diffuse intrinsic pontine glioma in the Belgian population: a 25 year experience.

Authors:  Dries Ruttens; Julie Messiaen; Alina Ferster; Caroline Piette; Stefan Schifflers; An Van Damme; Jutte van der Werff Ten Bosch; Joris Verlooy; Leen Willems; Sandra Jacobs
Journal:  J Neurooncol       Date:  2021-05-03       Impact factor: 4.130

3.  Long-Term Outcomes of Stereotactic Radiosurgery for Trigeminal, Facial, and Jugular Foramen Schwannoma in Comparison with Vestibular Schwannoma.

Authors:  Yuki Shinya; Hirotaka Hasegawa; Masahiro Shin; Takehiro Sugiyama; Mariko Kawashima; Atsuto Katano; Akinori Kashio; Kenji Kondo; Nobuhito Saito
Journal:  Cancers (Basel)       Date:  2021-03-07       Impact factor: 6.639

4.  Epidemiology and survival analyses of 333 adult glioma patients from Eastern Algeria (2008-2016).

Authors:  Sabrina Touati; Rachid Djekkoun; Mohamed El-Hadef El-Okki; Dalila Satta
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

5.  A Retrospective Study on Spinal Dissemination of Supratentorial Glioma.

Authors:  Jianxin Chen; Fan Yang; Qi Shi; Yuze Zhao; Hongyan Huang
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

6.  Hippocampal Dosimetry and Mnemonic Function Changes After Stereotactic Irradiation of Cavernous Sinus Meningiomas.

Authors:  Mikhail V Galkin; Gleb V Danilov; Maria Y Kaverina; Yulia V Strunina; Olga A Krotkova
Journal:  Cureus       Date:  2021-12-07

7.  MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting nuclear factor I/B (NFIB).

Authors:  Naveenkumar Perumal; Ranjana K Kanchan; David Doss; Noah Bastola; Pranita Atri; Ramakanth Chirravuri-Venkata; Ishwor Thapa; Raghupathy Vengoji; Shailendra K Maurya; David Klinkebiel; Geoffrey A Talmon; Mohd W Nasser; Surinder K Batra; Sidharth Mahapatra
Journal:  Acta Neuropathol Commun       Date:  2021-12-18       Impact factor: 7.801

8.  ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression.

Authors:  Kaiming Ma; Xin Chen; Weihai Liu; Yang Yang; Suhua Chen; Jianjun Sun; Changcheng Ma; Tao Wang; Jun Yang
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

9.  RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).

Authors:  Jianglong Xu; Jia Song; Menglin Xiao; Changsheng Wang; Qisong Zhang; Xiaoye Yuan; Shaohui Tian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

10.  Microfibrillar-associated protein 2 is a prognostic marker that correlates with the immune microenvironment in glioma.

Authors:  Wanzhen Xu; Ren Geng; Yao Zhao; Xiaoshan Ma; Yang Bai; Yining Jiang; Liyan Zhao; Yunqian Li
Journal:  Front Genet       Date:  2022-09-20       Impact factor: 4.772
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.